Last kr251.20 DKK
Change Today -6.70 / -2.60%
Volume 2.7M
NOVOB On Other Exchanges
Symbol
Exchange
OTC US
Copenhagen
New York
Frankfurt
Frankfurt
As of 11:02 AM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Heath Lukatch Ph.D.

Executive Officer of San Francisco Office, Novo Nordisk A/S
AgeTotal Calculated CompensationThis person is connected to 113 board members in 14 different organizations across 19 different industries.

See Board Relationships
46--

Background*

Mr. Heath Lukatch is a Partner at Novo A/S. Mr. Lukatch has been an Executive Officer at Novo Nordisk A/S since May 18, 2006. Mr. Lukatch joined Novo A/S in 2006. From 2001 to 2006, Mr. Lukatch served as the Managing Director and Head of Biotechnology Venture Investments at Sightline Partners. He joined Sightline Partners in January 2001. Mr. Lukatch served as an Engagement Manager of McKinsey & Company, Inc. Mr. Lukatch founded AutoMate Scientific, Inc. and served as ...

Read Full Background

Corporate Headquarters*

Novo Allé
Bagsvaerd, Capital Region of Denmark 2880

Denmark

Phone: 45 44 44 88 88
Fax: 45 44 49 05 55

Board Members Memberships*

Former Director
Director
Director
Former Director
Chairman of the Board
Chairman of The Board
Director
Director
Director
Director
2006-Present
Chairman and Chairman of Compensation, Nominating & Governance Committee
2007-Present
Director
2010-Present
Director
2011-Present
Chairman
2012-Present
Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
2014-Present
Director

Education*

PhD
The Leland Stanford Junior University
BA
University of California Berkeley

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVOB:DC kr251.20 DKK -6.70

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.5M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVO NORDISK A/S-B, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.